Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C9 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | ANXA2R | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | FAM78B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | PGC | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | AC129492.1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | SPN | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | MFAP1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | AC013461.1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | ZNF155 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | ADPGK | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |